Noticias
Proyecto de Inmunoterapia del Cáncer
Jacinto Convit
On June 7, 2010, a Venezuelan newspaper announced the successful development by Dr. Jacinto Convit of a new Cancer vaccine intended to fight colon, stomach and breast cancer.
On June 2010 the "Instituto de Biomedicina" published a note clarifying that they have been working for the last 3 years on a vaccine against cancer and it's still in development. During this time they have been evaluating a small group of 23 patients, mostly breast cancer and a few of colon, stomach and brain cancers. They have been giving patients an experimental model of immunotherapy against cancer, which have had encouraging results. They clarify that is a therapeutic and not prophylactic vaccine.
This vaccine is based on the idea that cancerous cells appear and propagate because the body doesn't detect them. A sample of the tumour mixed with formalin and BCG marks the malignous cells so the immune system reacts and attacks the cancer.
This experimental treatment has a big advantage over the use of traditional chemotherapy: It has very few side effects. BCG has been used against tuberculosis for a long time on millions of people with no consequences.